Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
-
28 Jun 21 EFFECT Notice of effectiveness
- 22 Jun 21 POS AM Prospectus update (post-effective amendment)
- 30 Jun 15 S-3MEF Registration of additional securities for an S-3
ReShape Lifesciences similar filings
Filing view
External links
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 25, 2021 |
Accession Number: | 0001104659-21-084093 | ||||||
Submission Type: | POS AM | ||||||
|